Ameritas Investment Partners, Inc. Imara Inc. Call Options Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMRA
# of Institutions
3Shares Held
104KCall Options Held
0Put Options Held
170KAbout IMARA Inc.
- Ticker IMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,287,300
- Market Cap $552M
- Description
- IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...